Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
| Реферат RUS | Реферат ENG | Литература | Полный текст |
| УДК: | DOI: https://doi.org/10.25276/2312-4911-2022-3-169-175 |
Татарникова Е.Б., Кривошеина О.И.
Применение диодного лазера в комплексном лечении хронического периферического увеита и синдрома «сухого глаза»
1. Heinz C, Schoonbrood S, Heiligenhaus A. Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. British Journal of Ophthalmology. 2014;98(8):1107–1111. doi: 10.1136/bjophthalmol-2013-304589
2. Luca C, Raffaella A, Sylvia M, Valentina M et al. Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up. Ocular immunology and inflammation. 2018;38(1):133–142. doi: 10.1007/s10792-016-0434-x
3. Jabs DA, Belfort RJr, Bodaghi B, Graham E, Holland GN, Lightman SL, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE. Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Syphilitic Uveitis. Am J Ophthalmol. 2021;228:182–191. doi: 10.1016/j.ajo.2021.03.039
4. Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis // Am J Ophthalmol. – 2021. – No. 228. – P. 72–79. doi: 10.1016/j.ajo.2021.03.044
5. Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Sarcoidosis-Associated Uveitis // Am J Ophthalmol. – 2021. – No. 228. P. 220–230. doi: 10.1016/j.ajo.2021.03.047
6. Standardization of Uveitis Nomenclature (SUN) Working Group. Development of Classification Criteria for the Uveitides // Am J Ophthalmol. – 2021. – No. 228. – P. 96–105. doi: 10.1016/j.ajo.2021.03.061
7. Jabs DA, Denniston AK, Dick АD, Dunn JP, Kramer M, Oden N, Okada AA, Palestine AG, Read RW, Thorne JE, Trusko BE, Yeh S. The Standardization Of Uveitis Nomenclature Sun Working Group Classification criteria for pars planitis. Am J Ophthalmol. 2021;S0002-9394(21):00170–7. doi: 10.1016/j.ajo.2021.03.045
8. Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type // Am J Ophthalmol. – 2021. – No. 228. – P. 159–164. doi: 10.1016/j.ajo.2021.03.054
9. Gonzales JA, Jap A, Chee SP. Pars Planitis and Other Intermediate Uveitis. Ophthalmology. 2019;7:21:777–779
10. Tomkins-Netzer O., Lightman S., Drye L. et al. Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results // Ophthalmology. – 2015. – Vol. 122. – No. 11. – P. 2351–2359. doi: 10.1016/j.ophtha.2015.07.036
11. Palsson S., Andersson Gronlund M., Skiljic D., Zetterberg M. Phacoemulsification with primary implantation of an intraocular lens in patients with uveitis // Clin Ophthalmol (Auckland, NZ). – 2017. – No. 11. – Р. 1549–1555. doi:10.2147/OPTH.S143886
12. Ness T., Boehringer D., Heinzelmann S. Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center // Orphanet journal of rare diseases. – 2017. – Vol. 12. – No. 1. – P. 81. doi: 10.1186/s13023-017-0638-9
13. Couret C, Ducloyer J-B, Touhami S et al. Treatment of noninfectious intermediate uveitis, posterior uveitis, or panuveitis. J Fr Ophtalmol. 2020 Apr;43(4):341–361. doi: 10.1016/j.jfo.2019.03.033
14. Jabs DA. Immunosuppression for the Uveitides. Ophthalmology. 2018 Feb;125(2):193–202. doi:10.1016/j.ophtha.2017.08.007
15. Darsova D, Pochop P, Stepankova J, Dotrelova D. Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment. Eur J Ophthalmol. 2018 Jan;28(1):98–102. doi: 10.5301/ejo.5001020
Страница источника: 169-175
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн





















